This is a routine strategic investment with no immediate earnings impact. Monitor for future milestone payments and any revenue contribution from Hopemark, but the near-term stock catalyst is minimal. The prior 20-F showed strong fundamentals, and this deal does not alter that trajectory.
Price Chart
Executive Summary
BrainsWay announced a minority-stake investment of $1.5 million (with potential for an additional $1.5 million via milestones) in Hopemark Health, a mental health provider in Illinois. This is a continuation of BrainsWay's strategy to partner with clinical platforms to expand access to its Deep TMS technology. The investment is small relative to BrainsWay's $52.2 million annual revenue and is not expected to materially impact near-term financials.
Key Facts
- BrainsWay will invest $1.5 million initially, with potential for an additional $1.5 million via milestone-based investments, for a minority position in Hopemark Health.
- The investment is in the form of a preferred, annually compounding security with a redemption mechanism.
- This is part of a series of similar minority-stake investments by BrainsWay in North American mental health providers.
- BrainsWay reported 2025 revenue of $52.2 million and net income of $7.6 million in its recent 20-F filing.
- The transaction is small-scale (up to $3 million total) and does not change BrainsWay's core business or financial outlook.
Financial Impact
Up to $3 million total investment, representing approximately 5.7% of BrainsWay's 2025 annual revenue of $52.2 million. The initial $1.5 million is about 2.9% of revenue.
Risk Factors
- Investment may not produce profitable returns, as noted in the forward-looking statement risk factors.
- Milestone-based additional investment may not materialize if Hopemark underperforms.
- Minority stake provides limited control over Hopemark's operations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003501 |
| Document: f6k_051726.htm | 0001171843-26-003501 |
| Document: 0001171843-26-003501-index-headers.html | 0001171843-26-003501 |
| Document: 0001171843-26-003501-index.html | 0001171843-26-003501 |
| Document: 0001171843-26-003501.txt | 0001171843-26-003501 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 16w ago | 6-K | $16.84 $15.13 | ▼ −10.15% | ▼ −14.24% | $12.60 (−25.18%) |
May 18, 2026 19w ago | 6-K | $16.84 $15.13 | ▼ −10.15% | ▼ −15.01% | $12.60 (−25.18%) |
May 13, 2026 20w ago | 6-K | $16.84 $15.13 | ▼ −10.15% | ▼ −14.59% | $12.60 (−25.18%) |
Apr 20, 2026 23w ago | 20-F | $13.55 $15.13 | ▲ +11.66% | ▲ +4.76% | $12.60 (−7.01%) |
Apr 15, 2026 24w ago | 6-K | $13.55 $15.13 | ▲ +11.66% | ▲ +3.52% | $12.60 (−7.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access